These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32725802)

  • 1. Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression.
    Zhou X; Jiao D; Dou M; Zhang W; Lv L; Chen J; Li L; Wang L; Han X
    J Cell Mol Med; 2020 Sep; 24(18):10648-10662. PubMed ID: 32725802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
    BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
    Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.
    Liu Y; Zhou J; Hu Y; Wang J; Yuan C
    Mol Cell Biochem; 2017 Jan; 425(1-2):47-58. PubMed ID: 27830358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
    Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
    Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1.
    Qin J; Li Y; Li Z; Qin X; Zhou X; Zhang H; Li S
    Clin Epigenetics; 2022 Apr; 14(1):51. PubMed ID: 35414117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein.
    Tripathi BK; Anderman MF; Bhargava D; Boccuzzi L; Qian X; Wang D; Durkin ME; Papageorge AG; de Miguel FJ; Politi K; Walters KJ; Doroshow JH; Lowy DR
    Nat Commun; 2021 Dec; 12(1):6941. PubMed ID: 34862367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.
    Ye L; Li F; Song Y; Yu D; Xiong Z; Li Y; Shi T; Yuan Z; Lin C; Wu X; Ren L; Li X; Song L
    Int J Cancer; 2018 Nov; 143(10):2602-2613. PubMed ID: 30151890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells.
    Han L; Zhang HC; Li L; Li CX; Di X; Qu X
    Cancer Biother Radiopharm; 2018 Aug; 33(6):241-251. PubMed ID: 30048163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signaling.
    Khan H; Ni Z; Feng H; Xing Y; Wu X; Huang D; Chen L; Niu Y; Shi G
    Phytomedicine; 2021 Oct; 91():153706. PubMed ID: 34517264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
    Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
    Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
    Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G
    Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin succinyl ester inhibits malignant proliferation and migration of hepatocellular carcinoma by suppressing the interaction of AR and EZH2.
    Khan H; Jia W; Yu Z; Zaib T; Feng J; Jiang Y; Song H; Bai Y; Yang B; Feng H
    Biomed Pharmacother; 2020 Aug; 128():110244. PubMed ID: 32464306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription.
    Wang M; Guo C; Wang L; Luo G; Huang C; Li Y; Liu D; Zeng F; Jiang G; Xiao X
    Cell Death Dis; 2018 Feb; 9(2):238. PubMed ID: 29445179
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Guo J; Zhu H; Li Q; Dong J; Xiong W; Yu K
    Aging (Albany NY); 2021 Apr; 13(8):11665-11677. PubMed ID: 33879635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK.
    Chang LC; Lin HY; Tsai MT; Chou RH; Lee FY; Teng CM; Hsieh MT; Hung HY; Huang LJ; Yu YL; Kuo SC
    Br J Pharmacol; 2014 Sep; 171(17):4010-25. PubMed ID: 24697523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis.
    Liu L; Fu Y; Zheng Y; Ma M; Wang C
    Phytomedicine; 2020 Nov; 78():153312. PubMed ID: 32866906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
    Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J
    Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.